Publication Name	World Journal of Clinical Cases
Manuscript ID	76923
Country	Italy

Received	2022-04-06 15:42
Peer-Review Started	2022-04-06 15:43
To Make the First Decision
Return for Revision	2022-06-16 01:15
Revised	2022-06-26 16:09
Second Decision	2022-07-08 02:52
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2022-07-11 18:45
Articles in Press	2022-07-11 18:45
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2022-07-19 09:37
Publish the Manuscript Online	2022-08-01 09:20

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Geriatrics & Gerontology
Manuscript Type	Minireviews
Article Title	Beta receptor blocker therapy for the elderly in the COVID-19 era
Manuscript Source	Invited Manuscript
All Author List	Elpidio Santillo and Monica Migale
ORCID	Author(s) ORCID Number Elpidio Santillo http://orcid.org/0000-0001-8914-1317
Funding Agency and Grant Number
Corresponding Author	Elpidio Santillo, MD, PhD, Staff Physician, Geriatric Rehabilitative Department, IRCCS-INRCA, C.da Mossa 2, Fermo 63900, Italy. elpisant@tin.it
Key Words	Adrenergic beta-antagonist; COVID-19; Aged; SARS-CoV-2; Cardiovascular diseases
Core Tip	This minireview offers an original and innovative summary of recent studies of the usefulness of beta blocker therapy for the elderly in the coronavirus disease 2019 (COVID-19) pandemic. We discuss the pharmacologic benefits of beta blocker therapy for older subjects and report the results of early studies highlighting the favorable effects of beta blockers on elderly patients affected by COVID-19.
Publish Date	2022-08-01 09:20
Citation	Santillo E, Migale M. Beta receptor blocker therapy for the elderly in the COVID-19 era. World J Clin Cases 2022; 10(23): 8088-8096
URL	https://www.wjgnet.com/2307-8960/full/v10/i23/8088.htm
DOI	https://dx.doi.org/10.12998/wjcc.v10.i23.8088

Full Article (PDF)	WJCC-10-8088.pdf
Full Article (Word)	WJCC-10-8088.docx
Manuscript File	76923_Auto_Edited-LS.docx
Answering Reviewers	76923-Answering reviewers.pdf
Audio Core Tip	76923-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	76923-Conflict-of-interest statement.pdf
Copyright License Agreement	76923-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	76923-Language certificate.pdf
Peer-review Report	76923-Peer-review(s).pdf
Scientific Misconduct Check	76923-Scientific editor work list.pdf
Scientific Editor Work List	76923-Bing-Wang LL-2.png
CrossCheck Report	76923-CrossCheck report.pdf